Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$17,224,593
in 1 filing
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. EcoR1 Capital, LLC +$17.2M Director 1 filing
  2. RENTON HOLLINGS −$249K Director sold 31% of stake
Date Insider Transaction Shares Price Value Owned after
2019-02-08 Ware J. Anthony Director Grant or award · Director Stock Option (Right to Buy) +6,000 6,000
2019-02-08 Topper James N Director Grant or award · Director Stock Option (Right to Buy) +6,000 6,000
2019-02-08 Suria Hamza President, CEO Grant or award · Employee Stock Option (Right to Buy) −94,000 94,000
2019-02-08 Schmid John P. Director Grant or award · Director Stock Option (Right to Buy) +6,000 6,000
2019-02-08 RENTON HOLLINGS Director Grant or award · Director Stock Option (Right to Buy) +6,000 6,000
2019-02-08 Piscitelli Dominic Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +35,000 35,000
2019-02-08 Lydon Nicholas Director Grant or award · Director Stock Option (Right to Buy) +6,000 6,000
2019-02-08 LOUMEAU ERIC J General Counsel Grant or award · Employee Stock Option (Right to Buy) +35,000 35,000
2019-02-08 Londei Marco Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +35,000 35,000
2019-02-08 FENTON DENNIS M Director Grant or award · Director Stock Option (Right to Buy) +6,000 6,000
2019-01-15 Londei Marco Chief Medical Officer Exercise or conversion +19,075 $6.93 $132K 41,452
2019-01-15 Londei Marco Chief Medical Officer Sale −4,181 $69.29 $290K 37,271
2019-01-15 Londei Marco Chief Medical Officer Sale −14,894 $70.04 $1.0M 22,377
2019-01-15 Londei Marco Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −19,075 51,148
2019-01-14 Suria Hamza President, CEO Exercise or conversion +40,000 $1.12 $45K 70,064
2019-01-14 Suria Hamza President, CEO Sale −27,760 $70.65 $2.0M 42,304
2019-01-14 Suria Hamza President, CEO Sale −12,240 $71.10 $870K 30,064
2019-01-14 Suria Hamza President, CEO Exercise or conversion · Employee Stock Option (Right to Buy) −40,000 89,284
2018-12-26 Londei Marco Chief Medical Officer Gift −122,500 22,377
2018-12-17 Londei Marco Chief Medical Officer Exercise or conversion +8,048 $0.70 $6K 152,925

Page 28 of 36 · 714 trades